Fischlein Theodor, Pfeiffer Steffen, Bagnardi Vincenzo, Santarpino Giuseppe
Department of Cardiac Surgery, Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany.
Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
J Cardiovasc Surg (Torino). 2017 Dec;58(6):916-930. doi: 10.23736/S0021-9509.17.09920-7. Epub 2017 May 26.
The aim of this study was to evaluate durability of Mitroflow and patterns of use compared with other aortic valves through a systematic review of the literature.
A total of 52 papers that included 33,630 patients met eligibility requirements that allowed summary statistical information to be determined regarding structural valve degeneration risk.
Mitroflow has been disporportionately implanted in patients to be at higher risk for structural valve degeneration.
Since Mitroflow valves were implanted more often in these high-risk patients, it was impossible to distinguish the effects of valve size or gender from valve type on structural valve degeneration risk.
本研究的目的是通过对文献的系统回顾，评估Mitroflow瓣膜的耐久性以及与其他主动脉瓣膜相比的使用模式。
共有52篇包含33630名患者的论文符合资格要求，从而能够确定有关结构性瓣膜退变风险的汇总统计信息。
Mitroflow瓣膜在结构性瓣膜退变风险较高的患者中植入比例过高。
由于Mitroflow瓣膜在这些高危患者中植入更为频繁，因此无法区分瓣膜尺寸或性别与瓣膜类型对结构性瓣膜退变风险的影响。
